New York Senator Voices Concern with New Credit Reporting Agency Scores
Sen. Chuck Schumer (D-NY) criticized credit reporting agencies on Sunday for newly developed scores that have little to do with credit, including the so called “Medication Adherence Score” and the “Income Insight Score.”
FICO’s “Medication Adherence Score” is a method of determining a patient’s compliance with taking medication prescribed by a doctor which taps pharmacy data including information about length of employment, verification of home address, their age and whether they live alone or not. These metrics are compiled into score which insurance companies use to determine how much in premiums to charge, according to Schumer.
Experian’s “Income Insight Score” is a system to predict a consumer’s income, extending its results to credit card issuers and home mortgage lenders.
Schumer has requested that FCC Chairman Jon Leibowitz investigate these new ratings and the credit bureaus’ legality in withholding the information from consumers as a possible violation of the Fair Credit Reporting Act.
“They’re back to their old tricks and they need to be reined in,” Schumer told a group of reporters in his office.
The FCRA requires credit bureaus to provide consumers with the same credit scores that credit card companies and banks utilize to determine loan and credit extension eligibility. Both Experian and FICO assert that these scores aren’t covered by the Fair Credit Reporting Act.
Schumer said that if the FCC concurs with him he will put together new legislation to extend to consumers the personal information he believes they’re entitled to.
“These new consumer scores are just the tip of the iceberg — they intend to keep scores on us about everything,” Schumer said.